Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_07-cv-05702/USCOURTS-cand-4_07-cv-05702-86/pdf.json

Nature of Suit Code: 190
Nature of Suit: Other Contract Actions
Cause of Action: 15:1 Antitrust Litigation

---

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

SMITHKLINE BEECHAM CORPORATION, 

d/b/a GLAXOSMITHKLINE,

Plaintiff,

 v.

ABBOTT LABORATORIES,

Defendant.

________________________________/

No. C 07-5702 CW

ORDER GRANTING 

MOTION TO CLARIFY 

(Dkt. #612); AND 

ALLOWING PARTIES 

TO FILE FURTHER 

BRIEFING WITH 

REGARD TO JURY 

INSTRUCTIONS, 

VERDICT FORM

Defendant Abbott Laboratories' Motion to Clarify the Minute 

Order Dated January 7, 2015 (Motion, Dkt. No. 612; Minute Order,

Dkt. No. 606), is GRANTED. The Court did, in fact, refuse to 

allow Plaintiff SmithKline Beecham, d/b/a GlaxoSmithKline, to 

substitute witnesses for the retrial; thus, the Court granted 

Defendant's Motion in Limine (Dkt. # 599). A corrected minute 

order will issue.

The Court has amended the preliminary jury instructions, the 

final jury instructions, and the verdict form, mostly to ensure 

consistency among these documents. The parties may file any 

objections to the January 23, 2015, versions of these documents, 

which are attached as exhibits to this Order, within seven days of 

the date of this Order. Each party may file a single brief, not 

to exceed five pages.

Dated: January 23, 2015

CLAUDIA WILKEN

United States District Judge

Case 4:07-cv-05702-CW Document 614 Filed 01/23/15 Page 1 of 1